Abstract
HTA304 The Impact of Different HTA Frameworks on Time to Patient Access: A Case Study Assessing the First Commercial Launch Indications for Lynparza, Tagrisso, Imfinzi, Calquence and Enhertu
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have